Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Froehner

Showing results (161-170 of 191) with videos related to

Pageof 20
Sort By:
Asian Journal of Andrology|January 5, 2017
Level of education and mortality after radical prostatectomyMichael Froehner, Rainer Koch, Stefan Propping, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 16, 2015
Integrated prostate cancer centers might cause an overutilization of radiotherapy for low-risk prostate cancer: A comparison of treatment trends in the United States and Germany from 2004 to 2011Benjamin Hager, Klaus Kraywinkel, Bastian Keck, et al.
Biomedicines|September 23, 2022
Postoperative Radiotherapy of Prostate Cancer: Adjuvant versus Early SalvageDaniel Wegener, Daniel M Aebersold, Marc-Oliver Grimm, et al.
Urologia Internationalis|October 30, 2019
Long-Term Mortality in Patients with Positive Lymph Nodes at the Time of Radical ProstatectomyMichael Froehner, Rainer Koch, Samaneh Farahzadi, et al.
European Urology|March 24, 2004
Prospective randomized trial comparing flutamide as adjuvant treatment versus observation after radical prostatectomy for locally advanced, lymph node-negative prostate cancerManfred P Wirth, Lothar Weissbach, Franz-Josef Marx, et al.
European Urology|July 22, 2015
Decreased Overall and Bladder Cancer-Specific Mortality with Adjuvant Chemotherapy After Radical Cystectomy: Multivariable Competing Risk AnalysisMichael Froehner, Rainer Koch, Ulrike Heberling, et al.
European Urology|August 24, 2014
Relationship of the number of removed lymph nodes to bladder cancer and competing mortality after radical cystectomyMichael Froehner, Vladimir Novotny, Ulrike Heberling, et al.
Nuklearmedizin. Nuclear Medicine|August 24, 2019
68Ga-RM2 PET in PSMA- positive and -negative prostate cancer patientsSebastian Hoberück, Enrico Michler, Gerd Wunderlich, et al.
The Prostate|August 22, 2006
Quantitative multi-gene expression profiling of primary prostate cancerUta Schmidt, Susanne Fuessel, Rainer Koch, et al.
Clinical Biochemistry|December 12, 2018
Evaluation of TERT promoter mutations in urinary cell-free DNA and sediment DNA for detection of bladder cancerSebastian Stasik, Karsten Salomo, Ulrike Heberling, et al.
Pageof 20

Showing results (161-170 of 191) with videos related to

Sort By:
Pageof 20
Asian Journal of Andrology|January 5, 2017
Level of education and mortality after radical prostatectomyMichael Froehner, Rainer Koch, Stefan Propping, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 16, 2015
Integrated prostate cancer centers might cause an overutilization of radiotherapy for low-risk prostate cancer: A comparison of treatment trends in the United States and Germany from 2004 to 2011Benjamin Hager, Klaus Kraywinkel, Bastian Keck, et al.
Biomedicines|September 23, 2022
Postoperative Radiotherapy of Prostate Cancer: Adjuvant versus Early SalvageDaniel Wegener, Daniel M Aebersold, Marc-Oliver Grimm, et al.
Urologia Internationalis|October 30, 2019
Long-Term Mortality in Patients with Positive Lymph Nodes at the Time of Radical ProstatectomyMichael Froehner, Rainer Koch, Samaneh Farahzadi, et al.
European Urology|March 24, 2004
Prospective randomized trial comparing flutamide as adjuvant treatment versus observation after radical prostatectomy for locally advanced, lymph node-negative prostate cancerManfred P Wirth, Lothar Weissbach, Franz-Josef Marx, et al.
European Urology|July 22, 2015
Decreased Overall and Bladder Cancer-Specific Mortality with Adjuvant Chemotherapy After Radical Cystectomy: Multivariable Competing Risk AnalysisMichael Froehner, Rainer Koch, Ulrike Heberling, et al.
European Urology|August 24, 2014
Relationship of the number of removed lymph nodes to bladder cancer and competing mortality after radical cystectomyMichael Froehner, Vladimir Novotny, Ulrike Heberling, et al.
Nuklearmedizin. Nuclear Medicine|August 24, 2019
68Ga-RM2 PET in PSMA- positive and -negative prostate cancer patientsSebastian Hoberück, Enrico Michler, Gerd Wunderlich, et al.
The Prostate|August 22, 2006
Quantitative multi-gene expression profiling of primary prostate cancerUta Schmidt, Susanne Fuessel, Rainer Koch, et al.
Clinical Biochemistry|December 12, 2018
Evaluation of TERT promoter mutations in urinary cell-free DNA and sediment DNA for detection of bladder cancerSebastian Stasik, Karsten Salomo, Ulrike Heberling, et al.
Pageof 20